Takeuchi Hijiri, Saoo Kousuke, Matsuda Yoko, Yokohira Masanao, Yamakawa Keiko, Zeng Yu, Miyazaki Masafumi, Fujieda Masaki, Kamataki Tetsuya, Imaida Katsumi
Onco-Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.
Cancer Lett. 2006 Mar 28;234(2):232-8. doi: 10.1016/j.canlet.2005.03.038.
We have reported that pretreatment by stomach tube with 8-methoxypsoralen (methoxsalen; 8-MOP), a potent human CYP2A6 inhibitor, strongly suppresses lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice (Cancer Res. 2003). Here, we examined inhibitory effects with administration in the diet. When the mice were 7 weeks of age, they received dietary supplementation with 8-MOP at concentrations of 1, 10 or 100 ppm for 3 days prior to a single dose of NNK (2mg/0.1 ml saline/mouse, i.p.) or an equal volume of saline (vehicle control). The experiment was terminated 16 weeks after the first 8-MOP treatment and lung proliferative lesions were analyzed. The incidences and multiplicities in the 8-MOP 100 ppm-treated group were significantly reduced as compared with values for the NNK alone group (P<0.001). Multiplicities of NNK-induced lung proliferative lesions were also reduced in a dose dependent manner (Spearman rank correlation coefficient; rho=-0.806, correction P<0.0001). Mouse CYP2A4 and CYP2A5 differ from each other only 11 amino acids, and are closely related to the human CYP2A6. One hour after the last of three daily doses of 8-MOP (0.5, 5 or 50mg/kg body weight in 0.2 ml corn oil, given by stomach tube) or an equal volume of corn oil (vehicle control), given to the mice at 7 weeks of age, isolation of lung and liver RNAs demonstrated no effects on CYP2A4 and CYP2A5 mRNA levels with 8-MOP. In conclusion, the results of this study showed that clear dose response inhibitory effects of 8-MOP on NNK-induced lung tumorigenesis in female A/J mice fed diets containing 8-MOP, due to inhibition of enzyme activity of CYP2A4 and CYP2A5, rather than their gene expression.
我们曾报道,通过胃管给予强效人CYP2A6抑制剂8-甲氧基补骨脂素(甲氧沙林;8-MOP)进行预处理,可强烈抑制4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)在雌性A/J小鼠中诱发的肺肿瘤发生(《癌症研究》,2003年)。在此,我们研究了通过饮食给予8-MOP的抑制作用。当小鼠7周龄时,在单次给予NNK(2mg/0.1ml生理盐水/小鼠,腹腔注射)或等体积生理盐水(溶剂对照)前3天,给予浓度为1、10或100ppm的8-MOP饮食补充。在首次给予8-MOP处理16周后终止实验,并分析肺部增殖性病变。与仅给予NNK组的值相比,8-MOP 100ppm处理组的发生率和增殖倍数显著降低(P<0.001)。NNK诱导的肺部增殖性病变的增殖倍数也呈剂量依赖性降低(Spearman等级相关系数;rho=-0.806,校正P<0.0001)。小鼠CYP2A4和CYP2A5彼此仅相差11个氨基酸,且与人类CYP2A6密切相关。在7周龄小鼠每日三次给予8-MOP(0.5、5或50mg/kg体重,溶于0.2ml玉米油,通过胃管给予)或等体积玉米油(溶剂对照)的最后一剂后1小时,分离肺和肝RNA显示8-MOP对CYP2A4和CYP2A5 mRNA水平无影响。总之,本研究结果表明,8-MOP对食用含8-MOP饮食的雌性A/J小鼠中NNK诱导的肺肿瘤发生具有明显的剂量反应抑制作用,这是由于抑制了CYP2A4和CYP2A5的酶活性,而非其基因表达。